STOCKHOLM, May 5, 2020 /PRNewswire/ -- On May 12th, 2020, at 08:00 am (CET), Moberg Pharma AB (OMX: MOB) will
present its Interim report for July
2019 - March 2020. Investors,
analysts and journalists are hereby invited to participate in a
teleconference at 3:00 pm (CET) on
the same date.
The teleconference will be hosted by Moberg Pharmas's CEO
Anna Ljung and VP Finance
Mark Beveridge. The presentation
will be held in English.
Date: May 12th,
2020
Time: 3:00 pm (CET)
To participate in the conference, please dial in on any number
below before the start of the call:
SE: +46 8 505 583 69
US: +1 833 249 84 04
The quarterly report and other information material will be made
public on:
http://www.mobergpharma.com/investors/calendarpresentations
For additional information, please contact:
Anna Ljung, CEO, Phone: + 46
70 766 60 30, e-post: anna.ljung@mobergpharma.se
Mark Beveridge, VP Finance, Phone: +
46 76 805 82 88, e-post: mark.beveridge@mobergpharma.se
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/moberg-pharma/r/moberg-pharma-s-interim-report-for-july-2019---march-2020-to-be-published-on-may-12---invitation-to-,c3103748
The following files are available for download:
|
https://mb.cision.com/Main/1662/3103748/1241578.pdf
|
Invitation to
teleconference 12th of May
|
View original
content:http://www.prnewswire.com/news-releases/moberg-pharmas-interim-report-for-july-2019---march-2020-to-be-published-on-may-12---invitation-to-teleconference-301052617.html
SOURCE Moberg Pharma